Investigation of Lifecore Biomedical, Inc.: Schall Law Firm Encourages Investors with Losses to Come Forward

LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims of violations of the securities laws on behalf of investors in Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) (NASDAQ:LFCR).

The investigation focuses on whether the company made false and/or misleading statements and/or failed to disclose relevant information to investors. Lifecore announced on March 20, 2024 that its board of directors had completed its review of strategic alternatives. They “unanimously concluded that the best way to maximize shareholder value at this time is to continue to execute the company’s stand-alone strategic plan.” The company also announced a leadership change with the appointment of a new CEO. On the news, Lifecore shares fell 35.6% in morning trading that same day.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You may also contact us through the firm’s website at www.schallfirm.com or by email at [email protected].

The Schall Law Firm represents investors throughout the world and specializes in securities class action litigation and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and professional rules.

View the original press release on accesswire.com.